, Tracking Stock Market Picks
Enter Symbol:
Evertec Inc. Common Stock (EVTC) [hlAlert]

down 11.85 %

Evertec Inc. Common Stock (EVTC) rated Buy with price target $24 by UBS

Posted on: Tuesday,  May 7, 2013  12:25 PM ET by UBS

UBS rated Buy Evertec Inc. Common Stock (NYSE: EVTC) on 05/07/2013, when the stock price was $20.25. Since
then, Evertec Inc. Common Stock has lost 11.85% as of 01/14/2016's recent price of $17.85.
If you would have followed this UBS's recommendation on EVTC, you would have lost 11.85% of your investment in 982 days.

Evotec AG (Evotec) is a drug discovery and development company focused on small molecule therapeutics. Evotec is developing treatments for diseases in the areas of neuroscience, pain, and inflammation. Evotec?s portfolio comprises five clinical drug candidates: EVT 101, a subtype selective NMDA receptor antagonist with potential for the treatment of Alzheimer?s disease, pain and depression, EVT 201, a partial positive allosteric modulator (pPAM) of the GABAA receptor complex for the treatment of insomnia, EVT 302, a MAO-B inhibitor in development for smoking cessation, a P2X7 antagonist for the treatment of inflammatory diseases, and a small molecule vanilloid receptor (VR1) antagonist for the treatment of pain in partnership with Pfizer. Evotec?s late stage preclinical research programs focus on EVT 103, a back-up compound to EVT 101, H3 antagonists for the treatment of cognitive disorders and/or sleep, as well as antagonists for the purinergic receptor P2X3 for the treatment of pain.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/7/2013 12:25 PM Buy
20.25 24.00
as of 12/13/2013
1 Week up  7.54 %
1 Month up  1.57 %
3 Months down  -2.55 %
1 YTD up  11.20 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy